FDA OKs quadripolar lead, 2 CRT-Ds

Candace Stuart | | Cardiovascular Business | Heart Failure

The FDA approved a quadripolar lead and two cardiac resynchronization therapy-defibrillator (CRT-D) devices for treatment in patients with heart failure.

According to device maker Medtronic, the newly approved Attain Performa Model 4298 quadripolar left-heart lead gives physicians more options by offering 16 pacing configurations. The lead has been shown to reduce the incidence of phrenic nerve stimulation.

The two Viva Quad devices—the XT and S CRT-Ds—incorporate different algorithms. The Viva Quad XT CRT-D uses the company’s AdaptivCRT algorithm, which in studies improved CRT response rate while reducing heart failure hospitalizations and readmission rates as well as the risk of atrial fibrillation. The Viva Quad S CRT-D integrates five algorithms.

Minneapolis-based Medtronic expects to make the lead and devices available in mid-September.

Candace Stuart, Contributor

Related Content

Medtronic using AI to identify more TAVR patients in need
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
Most heart failure patients miss out on guideline-recommended palliative care
CMS updates outpatient reimbursement policy for Barostim device
American Heart Association announces late-breaking research for Scientific Sessions 2024
Impella ECP confirmed to be safe for high-risk PCI—is FDA approval next?

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."